We appreciate Dr. Kapoor's interest in our article on the treatment of postherpetic neuralgia with the capsaicin 8 % patch \[[@CR1]\]. Postherpetic neuralgia can be very difficult to treat and the development of new therapies is needed, particularly given the potential for side effects from current systemic therapies \[[@CR2]\]. Vitamin C has low side effect liability and has been found to favorably affect one type of neuropathic pain, reducing the risk of complex regional pain syndrome following the wrist fracture \[[@CR3]\]. We agree that further investigation of this agent in other types of neuropathic pain, such as postherpetic neuralgia, is warranted.
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